Article Details

ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced ...

Retrieved on: 2025-09-18 08:51:42

Tags for this article:

Click the tags to see associated articles and topics

ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced .... View article details on hiswai:

Excerpt

TORONTO--(BUSINESS WIRE)--ProteinQure, a Toronto-based biotech company pioneering computational peptide drug discovery, today announced the ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo